Health X Platform share price
NSE: HEALTHXBSE: 533259Healthcare ServicesSmall Cap
Health X Platform Limited · Formerly Sastasundar Ventures · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2010
Last close ₹278.80up ₹3.40 (1.23%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹275.40.
28 Oct: open ₹276.40, high ₹280.00, low ₹270.20
52-week range of traded prices to 28 Oct 2026
₹252.50Low, 30 Mar 2026₹363.00High, 13 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹887 Cr1,526th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.38
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −9.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,57879.4% delivered
Results
Consolidated; ₹ crore.Health X Platform quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +28.8%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹447 Crup 19.55%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- ₹1.99 CrQuarter to Mar 2026: −₹13 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 0.4%
Revenue by quarter
Peak revenue ₹447 Cr, quarter to Jun 2026; lowest ₹274 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
Back to profit in the quarter to Jun 2026, ₹1.99 CrA loss in 4 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 274 | 281 | 286 | 298 | 301 | 346 | 374 | 447 |
| Net profit | −155 | −38 | 18 | 27 | −15 | 0 | −13 | 2 |
| Net margin | −56.6% | −13.4% | 6.1% | 8.9% | −5.1% | 0.1% | −3.5% | 0.4% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹1,319 Crup 18.75%
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹1.45 CrYear to Mar 2025: −₹134 Cr
- Net margin
- −0.1%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 8 of the 10 years shown
The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹159 Cr, differs from its quarters added, ₹165 Cr.
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 133 | 159 | 219 | 385 | 548 | 631 | 1,040 | 1,376 | 1,111 | 1,319 |
| Net profit | −29 | −12 | −38 | −52 | −17 | 978 | −99 | 6 | −134 | −1 |
| Net margin | −21.5% | −7.5% | −17.6% | −13.5% | −3.1% | 154.9% | −9.6% | 0.4% | −12.0% | −0.1% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Healthcare NetworkHealthcare Network, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1,283 Crup 17.93%97.3%
- Financial ServicesFinancial Services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹13 Crdown 41.61%1.0%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹23 Cr1.7%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Not shown, P/E: loss, last twelve months. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the year to Mar 2018: days before it are of the company before the change.Health X Platform PE ratio and valuation
Price to book
At or below today's level on 47% of 1,928 trading days since Nov 2018.
LowestHighest
Its median1.41Industry median1.64
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +6.0% | – | – | 0.0% |
| 3 years | +5.2% | – | – | 0.0% |
| 5 years | +17.1% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Health X Platform insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group20 purchases, 1 sale₹5.92 Cr₹7.50 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹1.58 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Health X Platform competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Health X Platform in market cap.Healthcare companies
Health X Platform is not on the chart: it has no P/E today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Suraksha DiagnosticSURAKSHA | 1,623 | 45.35 | 6.63 | +23.3% | +8.1% | 15.7% | 24.0% | 0.16% |
 Krsnaa DiagnosticsKRSNAA | 1,610 | 16.52 | 1.64 | +10.2% | +21.5% | 10.5% | 8.0% | 0.40% |
 3B Blackbio Dx3BBLACKBIO | 1,170 | 21.07 | 3.61 | +54.3% | +13.2% | 18.7% | 14.1% | 0.37% |
 One Global Service ProviderONEGLOBAL | 918 | 12.41 | 6.50 | +161.6% | +178.3% | 69.4% | 69.2% | 0.21% |
 Gaudium IVF and Women HealthGAUDIUMIVF | 717 | – | 4.71 | – | – | – | – | 0.00% |
| Credent Connect N CareCREDENT | 635 | – | – | – | – | – | – | 0.00% |
 Chandan HealthcareCHANDAN | 576 | – | – | – | – | – | – | 0.00% |
| Pramodini MedicarePRAMODINI | 240 | – | – | – | – | – | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Health X Platform dividend history
| Ex-date | Type | Per share |
|---|---|---|
| 23 Jul 2012 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹1.00 |
| 25 Jul 2011 | Final | ₹1.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Health X Platform announcements
Sep 2026
28 Sep · Meeting
Aug 2026
Health X Platform share price by year
Each calendar year to 2025.Health X Platform share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 295.10 | −6.9% | 328.35 | 208.23 |
| 2024 | 316.85 | −22.8% | 451.70 | 281.95 |
| 2023 | 410.20 | +45.9% | 477.05 | 220.55 |
| 2022 | 281.10 | −42.1% | 560.90 | 256.00 |
| 2021 | 485.60 | +276.7% | 562.00 | 113.15 |
| 2020 | 128.90 | +79.2% | 145.10 | 42.45 |
| 2019 | 71.95 | −24.3% | 122.25 | 65.95 |
| 2018 | 95.00 | −25.8% | 130.15 | 79.00 |
| 2017 | 128.00 | +72.7% | 149.90 | 70.90 |
| 2016 | 74.10 | −15.7% | 93.10 | 44.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 272.00 | 278.00 | 263.35 | 275.40 | 269.95 | 9,252 | 56.9% |
| 26 Oct 2026 | 266.90 | 286.00 | 261.45 | 269.50 | 275.60 | 2,390 | 56.4% |
| 23 Oct 2026 | 269.30 | 293.90 | 260.00 | 266.80 | 265.65 | 7,885 | 71.6% |
| 22 Oct 2026 | 272.55 | 274.90 | 267.10 | 268.85 | 269.43 | 1,014 | 92.7% |
| 21 Oct 2026 | 277.60 | 287.50 | 267.95 | 271.10 | 273.77 | 5,780 | 54.2% |
| 19 Oct 2026 | 283.00 | 290.90 | 278.75 | 279.80 | 280.76 | 2,512 | 80.8% |
| 16 Oct 2026 | 289.15 | 292.15 | 282.20 | 283.75 | 285.19 | 3,106 | 75.6% |
| 15 Oct 2026 | 289.90 | 299.40 | 282.05 | 283.50 | 291.28 | 5,592 | 63.1% |
| 14 Oct 2026 | 284.00 | 291.00 | 281.05 | 286.10 | 286.77 | 1,704 | 98.8% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- HEALTHX
- BSE code
- 533259
- ISIN
- INE019J01013
- Industry
- Healthcare Services
- Former symbols
- SASTASUNDR, MICROSEC
- Website
- www.healthxplatform.com
- CIN
- L65993WB1989PLC047002
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1989
- Registered office
- 7, "Azimganj House,, 2nd Floor,, Camca Street, Kolkata 700017, West Bengal
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments